Rates of vaccination decline in England, study shows
September 18, 2018Manufacturing and Production England, NHS, health, public health, vaccines, vacinnation
The number of people who are receiving the 12 routine childhood vaccinations has declined in proportion to the eligible population …
US Senate pass bipartisan bill to tackle opioid crisis
September 18, 2018Manufacturing and Production Senate, US, epidemic, opioid, opioid crisis, politics
The US Senate have passed a bipartisan bill aimed at combatting the opioid crisis. The bill, which was passed with …
US House of Representatives blocks drug pricing advert bill
September 18, 2018Manufacturing and Production Big Pharma, Drug pricing, HHS, Trump, Twitter, adverts
A ruling which would force pharmaceutical companies to disclose the price of their drugs in television advertisements has been set …
400 jobs to go as Novo Nordisk overhauls R&D operations
September 18, 2018Manufacturing and Production, Sales and Marketing Novo Nordisk, pharma
Novo Nordisk has revealed its intention to restructure its research & development operations “to accelerate the expansion and diversification of …
Sanofi’s Dupixent improves symptoms for adolescent atopic dermatitis patients
September 17, 2018Research and Development, Sales and Marketing Dupixent, EADV 2018, Sanofi, atopic dermatitis, pharma
Sanofi’s Dupixent (dupilumab) has made a strong showing as a monotherapy at Phase 3 in the treatment of moderate-to-severe atopic …
FDA approves AstraZeneca’s Lumoxiti for hairy cell leukaemia (HCL)
September 17, 2018Sales and Marketing AstraZeneca, HCL, Lumoxiti, leukaemia, rare diseases
AstraZeneca’s Lumoxiti has been approved for use for the treatment of relapsed or refractory hairy cell leukemia (HCL)in adults who …
Allergan acquires neurotoxin specialist Bonti in $195m deal
September 17, 2018Sales and Marketing Allergan, Bonti, Botox, Neurotoxin, acquisition, deal
The Dublin-headquartered multinational Allergan have agreed to acquire the clinical stage biotech Bonti in a deal worth more than $195 …
Teva shares soar after migraine treatment Ajovy approval
September 17, 2018Sales and Marketing FDA, Teva, US, ajovy, approval, israel
Shares in the Israeli pharma firm Teva soared on Sunday after the announcement that the US Food and Drug Administration …
NICE recommends Novartis combo as first-ever BRAF-targeted therapy for advanced post-surgery melanoma
September 17, 2018Sales and Marketing Cancer, NICE, Novartis, Tafinlar, mekinist, melanoma, pharma
NICE has taken the decision to recommend the first ever first BRAF-targeted therapy for use on the NHS in England …
Ex-GSK R&D head joins OxStem as CSO
September 14, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, OxStem, University of Oxford
OxStem, a regenerative drug discovery unit spun out from the University of Oxford, has brought on board ex-GlaxoSmithKline R&D exec …
Aileron Therapeutics name Dr Manuel Aivado as new President and CEO
September 14, 2018Aileron, CEO, Massachusetts, Watertown, appointments
The Watertown Massachusetts-based stapled peptide therapeutics specialist Aileron Therapeutics has appointed former SVP, Chief Medical & Scientific Officer Dr Manuel …
UCB brings promising plaque psoriasis data to EADV 2018
September 14, 2018Medical Communications, Research and Development EADV 2018, UCB, pharma, psoriasis
UCB has joined in on the wave of new psoriasis data emerging from the European Academy of Dermatology and Venereology …
Pfizer, Novartis, MSD, Novo and GSK halt operations in wake of Hurricane Florence
September 14, 2018Medical Communications GSK, Hurricane Florence, MSD, Novartis, Novo Nordisk, Pfizer, pharma
As Hurricane Florence begins to breach the Southeast Coast, major pharma firms have announced they are enacting contingency plans, including …
Top Ten most popular articles on Pharmafile.com this week
September 14, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myers Squibb, FDA, NICE, Novo Nordisk, Spinraza, brexit, bristol myers squibb, top 10
With the Pharmafocus team having avoided hurricane Florence and finally arriving back in the UK just last night, after stopping …
Scottish government invests £11m into Glasgow biotechnology centre
September 14, 2018Medical Communications Biotechnology, IBioIC, Scotland, glasgow, scottish government
The Scottish government is investing £11 million into the Glasgow-based Industrial Biotechnology Innovation Centre (IBioIC), an innovation centre which facilitates …
FDA launch plan to tackle e-cig epidemic
September 14, 2018Medical Communications FDA, Scott Gottlieb, USA, e-cig, juul
The FDA have announced a plan to crack down on the so-called ‘e-cig epidemic’, following revelations that vaping and use …
Living with fibromyalgia
September 13, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing fibromyalgia, patient experience
Scottish comedian Carina MacLeod recounts her life with fibromyalgia and the benefits of comedy in dealing with a chronic condition, …
Oxford Biomedica to expand with fourth site, creating 100 jobs
September 13, 2018Oxford BioMedica, pharma
Gene and cell therapy group Oxford Biomedica has announced plans to expand its business with a new site located not …
Novartis doubles down on Cosentyx’s efficacy in psoriasis with extensive real-world data
September 13, 2018Research and Development Cosentyx, Novartis, pharma, psoriasis
Novartis was yet another company to reveal new data on a psoriasis drug at the European Academy of Dermatology and …
Celgene’s Otezla produces “meaningful benefits” beyond traditional metrics in plaque psoriasis
September 13, 2018Research and Development Celgene, otezla, pharma, psoriasis
Celgene made its voice heard amongst the chorus of new psoriasis data emerging from the European Academy of Dermatology and …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
